Abbott Labs Sued By Activists Over AIDS Drug Patents

Law360, New York (December 2, 2005, 12:00 AM EST) -- Launching a new attack on Abbott Laboratories Inc.’s control of the lucrative AIDS treatment Kaletra, a group of international organizations has sued the pharmaceutical company in a Brazilian court to invalidate its patents for the drug.

If successful, the suit would trigger the drug’s massive generic reproduction in the country, without threat of legal action, only two months after the Brazilian government negotiated with Abbott for a huge reduction in the cost of the drug.

Experts contend that Brazil’s intellectual property laws, which are relatively new...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.